Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical
Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical applications and to increase sales and marketing to its target market (physicians). ePhysician claims 8000 users and more than 400,000 prescriptions sent using its software. The application suite enables doctors to transmit electronic prescriptions securely over the Internet, to capture diagnosis and billing information, and to access drug reference information. The investors included Dresdner Kleinwort Capital (which led the group), Benchmark Capital, CVS, and Palm Ventures.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.